Related Experiment Videos
[Combination therapy of antibiotics and intravenous immunoglobulin]
1Osaka Medical Center for Cancer and Cardiovascular Diseases.
Abstract:
A large scale multicenter randomized controlled study was conducted to evaluate the efficacy of intravenous immunoglobulin in combination with IPM/CS and AMK in 504 evaluable patients who did not respond by 3 day therapy with beta-lactum and aminoglucoside. Immunoglobulin 5 g was administered 3 days to the patients allocated to immunoglobulin group. A completely automatic computer evaluation was performed according to the criteria determined by the committee. The response rate was 61.5% in immunoglobulin group and 47.3% in control group(p < 0.001). Intravenous immunoglobulin is considered effective for severe infection when used as combination therapy with antibiotics.
Insights
Intravenous immunoglobulin (IVIG) plus antibiotics significantly improved severe infection treatment outcomes in a large study. IVIG therapy demonstrated a higher response rate compared to standard antibiotic treatment alone.
Area of Science:
- Infectious Diseases
- Immunology
- Clinical Medicine
Background:
- Severe infections pose significant treatment challenges.
- Standard antibiotic therapy may be insufficient for some patients.
- Exploring adjunctive therapies is crucial for improving outcomes.
Purpose of the Study:
- To evaluate the efficacy of intravenous immunoglobulin (IVIG) as an add-on therapy for severe infections.
- To compare outcomes in patients receiving IVIG plus antibiotics versus antibiotics alone.
Main Methods:
- A large-scale, multicenter randomized controlled trial involving 504 patients.
- Patients received either standard antibiotic therapy or IVIG (5g/day for 3 days) plus antibiotics.
- Treatment response was assessed using automated computer evaluation.
Main Results:
- The IVIG combination therapy group showed a significantly higher response rate (61.5%) compared to the control group (47.3%).
- The difference in response rates was statistically significant (p < 0.001).
Conclusions:
- Intravenous immunoglobulin is an effective adjunctive therapy for severe infections.
- Combining IVIG with antibiotics enhances treatment efficacy in non-responsive cases.